These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 18951049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R, Nadkarni A, Gorakshakar A, Phanasgaonkar S, Surve R, Subramaniam PG, Bondge N, Pujari K, Ghosh K, Mohanty D.
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis of thalassemia intermedia in Iran.
    Akbari MT, Izadi P, Izadyar M, Kyriacou K, Kleanthous M.
    Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
    [Abstract] [Full Text] [Related]

  • 4. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
    Verma IC, Kleanthous M, Saxena R, Fucharoen S, Winichagoon P, Raizuddin S, Khan SN, Akbari MT, Izadyar M, Kotea N, Old JM, Ioannou PA, Khan B.
    Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
    [Abstract] [Full Text] [Related]

  • 5. A large cohort of β(+)-thalassemia in Thailand: molecular, hematological and diagnostic considerations.
    Yamsri S, Singha K, Prajantasen T, Taweenan W, Fucharoen G, Sanchaisuriya K, Fucharoen S.
    Blood Cells Mol Dis; 2015 Feb; 54(2):164-9. PubMed ID: 25471338
    [Abstract] [Full Text] [Related]

  • 6. Clinical and hematologic features of beta0-thalassemia (frameshift 41/42 mutation) in Thai patients.
    Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Fucharoen S.
    Haematologica; 2001 Feb; 86(2):138-41. PubMed ID: 11224481
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
    Traeger-Synodinos J, Papassotiriou I, Metaxotou-Mavrommati A, Vrettou C, Stamoulakatou A, Kanavakis E.
    Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
    [Abstract] [Full Text] [Related]

  • 10. Molecular basis of β-thalassemia in the United Arab Emirates.
    Baysal E.
    Hemoglobin; 2011 Aug; 35(5-6):581-8. PubMed ID: 22074124
    [Abstract] [Full Text] [Related]

  • 11. Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.
    Kukreti R, Dash D, E VK, Chakravarty S, Das SK, De M, Talukder G.
    Am J Hematol; 2002 Aug; 70(4):269-77. PubMed ID: 12210807
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major.
    Sharma N, Das R, Kaur J, Ahluwalia J, Trehan A, Bansal D, Panigrahi I, Marwaha RK.
    Eur J Haematol; 2010 Jun; 84(6):531-7. PubMed ID: 20132300
    [Abstract] [Full Text] [Related]

  • 13. Molecular and hematological characterization of HPFH-6/Indian deletion-inversion Ggamma(Agammadeltabeta)0-thalassemia and Ggamma(Agammadeltabeta)0-thalassemia/HbE in Thai patients.
    Fucharoen S, Pengjam Y, Surapot S, Fucharoen G, Sanchaisuriya K.
    Am J Hematol; 2002 Oct; 71(2):109-13. PubMed ID: 12353310
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of gamma-globin promoters, HS-111 and 3'HS1, in beta-thalassemia intermedia patients associated with high levels of Hb F.
    Hamid M, Mahjoubi F, Akbari MT, Arab A, Zeinali S, Karimipoor M.
    Hemoglobin; 2009 Oct; 33(6):428-38. PubMed ID: 19958188
    [Abstract] [Full Text] [Related]

  • 15. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.
    J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of a β-thalassemia intermedia patient presenting inferior vena cava thrombosis: interaction of the β-globin erythroid Krüppel-like factor binding site mutation with Hb E and α(+)-thalassemia.
    Prajantasen T, Teawtrakul N, Fucharoen G, Fucharoen S.
    Hemoglobin; 2014 Feb; 38(6):451-3. PubMed ID: 25370867
    [Abstract] [Full Text] [Related]

  • 17. Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand.
    Yamsri S, Sanchaisuriya K, Fucharoen G, Sae-Ung N, Fucharoen S.
    Blood Cells Mol Dis; 2011 Aug 15; 47(2):120-4. PubMed ID: 21664157
    [Abstract] [Full Text] [Related]

  • 18. Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease.
    Sripichai O, Munkongdee T, Kumkhaek C, Svasti S, Winichagoon P, Fucharoen S.
    Ann Hematol; 2008 May 15; 87(5):375-9. PubMed ID: 18026953
    [Abstract] [Full Text] [Related]

  • 19. Frequency of positive XmnIGgamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation.
    Neishabury M, Azarkeivan A, Najmabadi H.
    Blood Cells Mol Dis; 2010 May 15; 44(2):95-9. PubMed ID: 19892574
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
    Prakobkaew N, Fucharoen S, Fuchareon G, Siriratmanawong N.
    Eur J Haematol; 2014 Jan 15; 92(1):73-9. PubMed ID: 24112054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.